VNDA
NASDAQ
$5.32
Vanda Pharmaceuticals Inc (VNDA)
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is headquartered in Washington, the District of Columbia.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $14.12 (+165.41%)
Market Cap
$352M
Free Cash Flow Yield
-36.19%
Beta (5Y)
0.64
Price Chart
Valuation
Market Cap$352M
Forward P/E103.09
P/S1.61
P/B1.28
Profitability
Total Revenue (TTM)$218M
Gross Profit (TTM)$205M
EBITDA-$159M
Profit Margin-93.9%
Operating Margin-97.1%
EPS-$4.04
Financial Health
Free Cash Flow Yield-36.19%
Growth & Risk
Revenue 5Y CAGR-2.94%
Beta (5Y)0.64
Sharpe Ratio0.45